Paper39598409
Design, Development and Immunogenicity Study of a Multi-Epitope Vaccine Prototype Against SARS-CoV-2.
Atanasova M and 8 others. Pharmaceuticals (Basel), 2024. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. Design, Development and Immunogenicity Study of a Multi-Epitope Vaccine Prototype Against SARS-CoV-2. Papers, record 39598409. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39598409
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Design, Development and Immunogenicity Study of a Multi-Epitope Vaccine Prototype Against SARS-CoV-2.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| KP-06-DK1/2/2021 | Bulgarian Science Fund | PubMed | ||
| BG05M2OP001-1.001-0003 | Science and Education for Smart Growth Operational Program | PubMed | ||
| BG05M2OP001-1.002-0001-C04 | Science and Education for Smart Growth Operational Program | PubMed | ||
| D01-325/2023 | National Roadmap for Research Infrastructure | PubMed |
Source PubMed
References47
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32227757 | Developing Covid-19 Vaccines at Pandemic Speed. | N Engl J Med | 2020 | https://conductscience.org/library/papers/32227757 | PubMed |
| 2 | 38704475 | Immunoinformatics design of a structural proteins driven multi-epitope candidate vaccine against different SARS-CoV-2 variants based on fynomer. | Sci Rep | 2024 | https://conductscience.org/library/papers/38704475 | PubMed |
| 3 | 32473127 | Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals. | Cell | 2020 | https://conductscience.org/library/papers/32473127 | PubMed |
| 4 | 32406916 | NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data. | Nucleic Acids Res | 2020 | https://conductscience.org/library/papers/32406916 | PubMed |
| 5 | 35594660 | Design, immunogenicity, and efficacy of a pan-sarbecovirus dendritic-cell targeting vaccine. | EBioMedicine | 2022 | https://conductscience.org/library/papers/35594660 | PubMed |
| 6 | 20576624 | EpiTOP--a proteochemometric tool for MHC class II binding prediction. | Bioinformatics | 2010 | https://conductscience.org/library/papers/20576624 | PubMed |
| 7 | 12589760 | Crystal structure of MHC class II I-Ab in complex with a human CLIP peptide: prediction of an I-Ab peptide-binding motif. | J Mol Biol | 2003 | https://conductscience.org/library/papers/12589760 | PubMed |
| 8 | 36352060 | Bioinformatics approach for the construction of multiple epitope vaccine against omicron variant of SARS-CoV-2. | Sci Rep | 2022 | https://conductscience.org/library/papers/36352060 | PubMed |
| 9 | 35156709 | HLA-DR polymorphism in SARS-CoV-2 infection and susceptibility to symptomatic COVID-19. | Immunology | 2022 | https://conductscience.org/library/papers/35156709 | PubMed |
| 10 | 16533401 | EpiJen: a server for multistep T cell epitope prediction. | BMC Bioinformatics | 2006 | https://conductscience.org/library/papers/16533401 | PubMed |
| 11 | 36360904 | HLA Genotypes in Patients with Infection Caused by Different Strains of SARS-CoV-2. | Int J Environ Res Public Health | 2022 | https://conductscience.org/library/papers/36360904 | PubMed |
| 12 | 21231985 | Analysis of HLA-A24-restricted peptides of carcinoembryonic antigen using a novel structure-based peptide-HLA docking algorithm. | Cancer Sci | 2011 | https://conductscience.org/library/papers/21231985 | PubMed |
| 13 | 22039305 | Affinity thresholds for naive CD8+ CTL activation by peptides and engineered influenza A viruses. | J Immunol | 2011 | https://conductscience.org/library/papers/22039305 | PubMed |
| 14 | 10733534 | Chronic viral hepatitis and the human genome. | Hepatology | 2000 | https://conductscience.org/library/papers/10733534 | PubMed |
| 15 | 34278794 | AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings. | J Chem Inf Model | 2021 | https://conductscience.org/library/papers/34278794 | PubMed |
| 16 | 34066901 | Peptide-Based Vaccines: Foot-and-Mouth Disease Virus, a Paradigm in Animal Health. | Vaccines (Basel) | 2021 | https://conductscience.org/library/papers/34066901 | PubMed |
| 17 | 35818892 | The association of human leucocyte antigen (HLA) alleles with COVID-19 severity: A systematic review and meta-analysis. | Rev Med Virol | 2023 | https://conductscience.org/library/papers/35818892 | PubMed |
| 18 | 35803932 | A third vaccination with a single T cell epitope confers protection in a murine model of SARS-CoV-2 infection. | Nat Commun | 2022 | https://conductscience.org/library/papers/35803932 | PubMed |
| 19 | 23661105 | EpiDOCK: a molecular docking-based tool for MHC class II binding prediction. | Protein Eng Des Sel | 2013 | https://conductscience.org/library/papers/23661105 | PubMed |
| 20 | 31611696 | Robust prediction of HLA class II epitopes by deep motif deconvolution of immunopeptidomes. | Nat Biotechnol | 2019 | https://conductscience.org/library/papers/31611696 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42746578 | Reverse vaccinology and immunoinformatics identify multi-epitope vaccine candidates against molluscum contagiosum virus. | Biol Methods Protoc | 2026 | https://conductscience.org/library/papers/42746578 | PubMed |
| 42463610 | Computational structural dynamics and immunoinformatic analysis of EIEC IpaH4.5 targeting immunoprophylaxis design against bacillary dysentery. | Mol Divers | 2026 | https://conductscience.org/library/papers/42463610 | PubMed |
| 42288920 | A protocol for computational design of mRNA vaccines with high functionality and specificity. | Biol Direct | 2026 | https://conductscience.org/library/papers/42288920 | PubMed |
| 42115669 | Domain arrangement-driven immunogenicity of a computationally designed mRNA vaccine targeting PPE68, IrtA, and PE9 of Mycobacterium tuberculosis. | Sci Rep | 2026 | https://conductscience.org/library/papers/42115669 | PubMed |
| 40093955 | The Predictive Value of Soluble Fms-Like Tyrosine Kinase-1 for Prognosis in COVID-19 Patients. | J Inflamm Res | 2025 | https://conductscience.org/library/papers/40093955 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ACE2 | 59272 | PubTator's text mining | https://conductscience.org/library/genes/59272 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39598409
GET https://conductscience.org/api/papers/v1/39598409/references?page=2